PARTNER NEWS:Thu, Mar 28, 8:25 AM, Zacks
Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
Omega Therapeutics (OMGA) delivered earnings and revenue surprises of 19.57% and 6.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Tue, Mar 26, 9:21 AM, Zacks
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies regulatory filing.